Treatment with botulinum toxin A appears to improve tear production and stability and relieve symptoms in patients with dry ...

A high-stakes legal fight between Regeneron and Amgen over the blockbuster eye drug Eylea is putting the U.S. patent system ...

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...